# Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema

> **NCT00231023** · PHASE2 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 10 (—)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **DRUG:** Peribulbar Triamcinolone Acetonide

## Key facts

- **NCT ID:** NCT00231023
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 10 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00231023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00231023, "Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00231023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*